Jason T. Rich

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 9 papers. Top paper: “Neoadjuvant and Adjuvant Pembrolizumab in Resectable Locally Advanced, Human Papillomavirus–Unrelated Head and Neck Cancer: A Multicenter, Phase II Trial”.

Neoadjuvant and Adjuvant Pembrolizumab in Resectable Locally Advanced, Human Papillomavirus–Unrelated Head and Neck Cancer: A Multicenter, Phase II Trial

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-1695

N/A

7.0DataRank · unranked

368 citations

Katie M. Campbell, Ann Marie Egloff, Paul Zolkind, Zachary L. Skidmore, Brian Nussenbaum +39 more

Targeted Proteomic Quantitation of NRF2 Signaling and Predictive Biomarkers in HNSCC

Molecular & Cellular Proteomics(2023)10.1016/j.mcpro.2023.100647

N/A

0.646DataRank · unranked

20 citations

Emily Wilkerson, Li Guan, Kyle M. LaPak, Travis P. Schrank, Brittany Holmes +15 more

Low‐risk human papilloma virus positive oropharyngeal cancer with one positive lymph node: Equivalent outcomes in patients treated with surgery and radiation therapy versus surgery alone

Head & Neck(2021)10.1002/hed.26642

N/A

0DataRank · unranked

1 citations

C. Burton Wood, Angela L. Mazul, Thomas F. Barrett, Randal C. Paniello, Jason T. Rich +9 more

Factors predicting pharyngocutaneous fistula in patients after salvage laryngectomy for laryngeal malignancy – A multicenter collaborative cohort study

Oral Oncology(2022)10.1016/j.oraloncology.2022.106089

N/A

0DataRank · unranked

13 citations

Joel Davies, John R. de Almeida, Jason T. Rich, Mario Orsini, Antoine Eskander +15 more

503 Cytotoxic revival is implicated in response to neoadjuvant PD-1 blockade for head and neck squamous cell carcinoma

Regular and Young Investigator Award Abstracts(2022)10.1136/jitc-2022-sitc2022.0503

N/A

0DataRank · unranked

2 citations

Giacomo Oliveira, Ann Marie Egloff, Zexiang Zeng, Rebecca D. Chernock, Liye Zhou +33 more

Preexisting tumor-resident T cells with cytotoxic potential associate with response to neoadjuvant anti–PD-1 in head and neck cancer

Science Immunology(2023)10.1126/sciimmunol.adf4968

N/A

0DataRank · unranked

118 citations

Ann Marie Egloff, Alexander B. Afeyan, Jacquelyn O. Wolff, Zexiang Zeng, Rebecca D. Chernock +34 more

Audiologic Follow‐up in Patients With Head and Neck Cancer Treated With Cisplatin and Radiation

The Laryngoscope(2023)10.1002/lary.30682

N/A

0DataRank · unranked

10 citations

Emma Y. Travis, Susan K. Wong, Cathryn Collopy, Kate McClannahan, Amanda J. Ortmann +12 more

Immune Cell Deconvolution Reveals Possible Association of γδ T Cells with Poor Survival in Head and Neck Squamous Cell Carcinoma

Cancers(2023)10.3390/cancers15194855

N/A

0DataRank · unranked

3 citations

Yize Li, Angela L. Mazul, Victoria X. Yu, Wade L. Thorstad, Jason T. Rich +11 more

Neoadjuvant and Adjuvant Pembrolizumab in Resectable Locally Advanced, Human Papillomavirus-Unrelated Head and Neck Cancer: A Multicenter, Phase 2 Trial

medRxiv(2020)10.1101/2020.03.18.20037846

N/A

0DataRank · unranked

4 citations

Katie M. Campbell, Ann Marie Egloff, Paul Zolkind, Zachary L. Skidmore, Brian Nussenbaum +39 more